Picture of Diaceutics logo

DXRX Diaceutics Income Statement

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsAdventurousSmall CapHigh Flyer

Annual income statement for Diaceutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
C2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue10.413.412.713.919.5
Cost of Revenue
Gross Profit6.810.39.4612.216.7
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses9.1712.713.413.418.9
Operating Profit1.20.74-0.6580.550.575
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes0.8770.497-0.6820.4620.564
Provision for Income Taxes
Net Income After Taxes0.6320.3980.2630.5610.724
Net Income Before Extraordinary Items
Net Income0.6320.3980.2630.5610.724
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income0.6320.3980.2630.5610.724
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.0110.0230.0070.0070.008
Dividends per Share